Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib.
Inanc N, Abacar KY, Ozturk MA, Tufan A, Karadeniz H, Sari I, Can G, Erez Y, Pehlivan Y, Dalkilic HE, Ocak T, Cefle A, Yazici A, Senel AS, Akar S, Durak-Ediboğlu E, Koca SS, Piskin-Sagir R, Yilmaz S, Gulcemal S, Soysal-Gunduz O, Basibuyuk CS, Alkan S, Cesur TY, Onen F. Inanc N, et al. Among authors: alkan s. J Clin Rheumatol. 2023 Dec 1;29(8):365-369. doi: 10.1097/RHU.0000000000002026. Epub 2023 Sep 19. J Clin Rheumatol. 2023. PMID: 37724891 Free PMC article.
Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data.
Kalyoncu U, Bilgin E, Erden A, Satış H, Tufan A, Tekgöz E, Ateş A, Coşkun BN, Yağız B, Küçükşahin O, Yazısız V, Kimyon G, Bes C, Başıbüyük CS, Alkan S, Cesur TY, Ertenli İ, Kiraz S. Kalyoncu U, et al. Among authors: alkan s. Clin Exp Rheumatol. 2022 Nov;40(11):2071-2077. doi: 10.55563/clinexprheumatol/9h6dtb. Epub 2022 Jan 25. Clin Exp Rheumatol. 2022. PMID: 35084323 Free article.
Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study.
Direskeneli H, Karadag O, Ates A, Tufan A, Inanc N, Koca SS, Cetin GY, Akar S, Cinar M, Yilmaz S, Yilmaz N, Dalkilic E, Bes C, Yilmazer B, Sahin A, Ersözlü D, Tezcan ME, Sen N, Keser G, Kalyoncu U, Armagan B, Hacibedel B, Helvacioglu K, Cesur TY, Basibuyuk CS, Alkan S, Gunay LM. Direskeneli H, et al. Among authors: alkan s. Rheumatol Adv Pract. 2022 Sep 2;6(3):rkac071. doi: 10.1093/rap/rkac071. eCollection 2022. Rheumatol Adv Pract. 2022. PMID: 36133962 Free PMC article.
Population-based, first-tier genomic newborn screening in the maternity ward.
Boemer F, Hovhannesyan K, Piazzon F, Minner F, Mni M, Jacquemin V, Mashhadizadeh D, Benmhammed N, Bours V, Jacquinet A, Harvengt J, Bulk S, Dideberg V, Helou L, Palmeira L, Dangouloff T; BabyDetect Expert Panel; Servais L. Boemer F, et al. Nat Med. 2025 Jan 28. doi: 10.1038/s41591-024-03465-x. Online ahead of print. Nat Med. 2025. PMID: 39875687
Comparison of Piperacillin-tazobactam and Vancomycin (TZP-VAN) with Piperacillin-tazobactam and Teicoplanin (TZP-TEI) for the risk of Acute Kidney Injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study.
Aslan AT, Kara E, Köksal G, Bilir Y, Saraçoğlu KT, Eser F, Güner R, Alkan S, D'Avino A, Escudero-Sanchez R, Kutluca K, Kaya SY, Saltoğlu N, Loiacono L, Coladonato S, Giacomo PD, Cascio A, Pallotto C, Francisci D, Öztürk B, Pınar A, Dağ O, Harris PNA, Paterson DL, Akova M. Aslan AT, et al. Among authors: alkan s. Int J Antimicrob Agents. 2025 Jan 16:107446. doi: 10.1016/j.ijantimicag.2025.107446. Online ahead of print. Int J Antimicrob Agents. 2025. PMID: 39826571 Free article.
Amphotericin B Resistant Aspergillus spp.: Report of Two Cases.
Kaya A, Kaya SY, Balkan İİ, Alkan S, Kurt AF, Elverdi T, Ürkmez S, Öngören Ş, Aygün G. Kaya A, et al. Among authors: alkan s. Infect Dis Clin Microbiol. 2024 Dec 19;6(4):343-348. doi: 10.36519/idcm.2024.371. eCollection 2024 Dec. Infect Dis Clin Microbiol. 2024. PMID: 39744663 Free PMC article.
Widening the infantile hypotonia with psychomotor retardation and characteristic Facies-1 Syndrome's clinical and molecular spectrum through NALCN in-silico structural analysis.
Vecchio D, Macchiaiolo M, Gonfiantini MV, Panfili FM, Petrizzelli F, Liorni N, Cortellessa F, Sinibaldi L, Rana I, Agolini E, Cocciadiferro D, Colantoni N, Semeraro M, Rizzo C, Deodati A, Cotugno N, Caggiano S, Verrillo E, Nucci CG, Alkan S, Saraiva JM, De Sá J, Almeida PM, Krishna J, Buonuomo PS, Martinelli D, Dionisi Vici C, Caputo V, Bartuli A, Novelli A, Mazza T. Vecchio D, et al. Among authors: alkan s. Front Genet. 2024 Dec 11;15:1477940. doi: 10.3389/fgene.2024.1477940. eCollection 2024. Front Genet. 2024. PMID: 39722796 Free PMC article.
339 results